Amygdala dynorphin/κ opioid receptor system modulates depressive-like behavior in mice following chronic social defeat stress
- 25 May 2021
- journal article
- research article
- Published by Springer Science and Business Media LLC in Acta Pharmacologica Sinica
- Vol. 43 (3), 577-587
- https://doi.org/10.1038/s41401-021-00677-6
Abstract
Major depression disorder is a severe and recurrent neuropsychological disorder characterized by lowered mood and social activity and cognitive impairment. Owing to unclear molecular mechanisms of depression, limited interventions are available in clinic. In this study we investigated the role of dynorphin/κ opioid receptor system in the development of depression. Mice were subjected to chronic social defeat stress for 14 days. Chronic social defeat stress induced significant social avoidance in mice characterized by decreased time duration in the interaction zone and increased time duration in the corner zone. Pre-administration of a κ opioid receptor antagonist norBNI (10 mg/kg, i.p.) could prevent the development of social avoidance induced by chronic social defeat stress. Social avoidance was not observed in κ opioid receptor knockout mice subjected to chronic social defeat stress. We further revealed that social defeat stress activated c-fos and ERK signaling in the amygdala without affecting the NAc, hippocampus and hypothalamus, and ERK activation was blocked by systemic injection of norBNI. Finally, the expression of dynorphin A, the endogenous ligand of κ opioid receptor, was significantly increased in the amygdala following social defeat stress; microinjection of norBNI into the amygdala prevented the development of depressive-like behaviors caused by social defeat stress. The present study demonstrates that upregulated dynorphin/κ opioid receptor system in the amygdala leads to the emergence of depression following chronic social defeat stress, and sheds light on κ opioid receptor antagonists as potential therapeutic agents for the prevention and treatment of depression following chronic stress.Keywords
This publication has 75 references indexed in Scilit:
- Major depressive disorder: new clinical, neurobiological, and treatment perspectivesThe Lancet, 2012
- Blockade of kappa opioid receptors attenuates the development of depressive-like behaviors induced by cocaine withdrawal in ratsNeuropharmacology, 2012
- Repeated Exposure to the κ-Opioid Receptor Agonist Salvinorin A Modulates Extracellular Signal-Regulated Kinase and Reward SensitivityBiological Psychiatry, 2011
- Kappa Opioid Receptor Signaling in the Basolateral Amygdala Regulates Conditioned Fear and Anxiety in RatsBiological Psychiatry, 2011
- Selective p38α MAPK Deletion in Serotonergic Neurons Produces Stress Resilience in Models of Depression and AddictionNeuron, 2011
- Kinase cascades and ligand-directed signaling at the kappa opioid receptorPsychopharmacology, 2010
- Dynorphin, stress, and depressionBrain Research, 2010
- Kappa-opioid ligands in the study and treatment of mood disordersPharmacology & Therapeutics, 2009
- 30 years of dynorphins — New insights on their functions in neuropsychiatric diseasesPharmacology & Therapeutics, 2009
- Genetic variation in cortico-amygdala serotonin function and risk for stress-related diseaseNeuroscience & Biobehavioral Reviews, 2008